1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 49, 05/Dec/2024
  4. Article
Rapid communication Open Access
Like 0
Download

SDG 3: Antimicrobial resistance

Abstract

Since April 2024, a pertussis epidemic has been ongoing in Finland with 2,215 notified cases by end October. Of them, 30.1% (n = 667) were aged 10–14 years. Of the 462 isolates characterised, one was macrolide-resistant (minimum inhibitory concentration (MIC) of erythromycin, azithromycin and clarithromycin > 256 μg/mL). The resistant isolate was serotype FIM2, vaccine antigen pertactin-deficient and harboured allele. The emergence of macrolide-resistant in Europe is worrisome and its rapid identification is important.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.49.2400765
2024-12-05
2025-02-05
/content/10.2807/1560-7917.ES.2024.29.49.2400765
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/49/eurosurv-29-49-1.html?itemId=/content/10.2807/1560-7917.ES.2024.29.49.2400765&mimeType=html&fmt=ahah

References

  1. Finnish Institute for Health and Welfare (THL). Finnish National Infectious Diseases Register, statistical database - cases. Helsinki: THL; 2 Dec 2024. Available from: https://sampo.thl.fi/pivot/prod/en/ttr/cases/fact_ttr_cases?&row=nidrreportgroup-878152&column=yearmonth-878344
  2. European Commission (EC). Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. Brussels: EC; 22 Jun 2018. Available from: https://eur-lex.europa.eu/eli/dec_impl/2018/945/oj#:~:text=mumps%20virus%20strain-,3.30.%C2%A0%C2%A0%C2%A0PERTUSSIS,-Clinical%20Criteria
  3. Heinonen S, Nohynek H, Melin M, Jordman C, Kärkkäinen S, Nyqvist A, et al. Työpaperi 40/2024, Hinkuyskärokotteet raskaana oleville: Suosituksen perusteet. [Working document 40/2024, whooping cough vaccines for pregnant people]. Helsinki: Finnish Institute for Health and Welfare (THL); 2024. Finnish. Available from: https://www.julkari.fi/bitstream/handle/10024/149632/URN_ISBN_978-952-408-334-8.pdf?sequence=1&isAllowed=y
  4. Niinikoski V, Barkoff AM, Mertsola J, He Q. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation. Clin Microbiol Infect. 2024;30(5):683.e1-3.  https://doi.org/10.1016/j.cmi.2024.01.021  PMID: 38310999 
  5. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, et al. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine. 2007;25(5):918-26.  https://doi.org/10.1016/j.vaccine.2006.09.012  PMID: 17030495 
  6. Barkoff AM, Mertsola J, Guillot S, Guiso N, Berbers G, He Q. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol. 2012;19(10):1703-4.  https://doi.org/10.1128/CVI.00367-12  PMID: 22914363 
  7. Barkoff AM, Mertsola J, Pierard D, Dalby T, Hoegh SV, Guillot S, et al. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill. 2019;24(7):1700832.  https://doi.org/10.2807/1560-7917.ES.2019.24.7.1700832  PMID: 30782265 
  8. Kallonen T, Mertsola J, Mooi FR, He Q. Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect. 2012;18(10):E377-9.  https://doi.org/10.1111/j.1469-0691.2012.04000.x  PMID: 22909320 
  9. Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol. 2003;41(3):1167-72.  https://doi.org/10.1128/JCM.41.3.1167-1172.2003  PMID: 12624047 
  10. Feng Y, Chiu CH, Heininger U, Hozbor DF, Tan TQ, von König CW. Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative. Lancet Reg Health West Pac. 2021;8:100098.  https://doi.org/10.1016/j.lanwpc.2021.100098  PMID: 34327426 
  11. Centers for Disease Control and Prevention (CDC). Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994. MMWR Morb Mortal Wkly Rep. 1994;43(44):807-10. PMID: 7968996 
  12. Guillot S, Descours G, Gillet Y, Etienne J, Floret D, Guiso N. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis. 2012;18(6):966-8.  https://doi.org/10.3201/eid1806.120091  PMID: 22608348 
  13. Wang Z, Han R, Liu Y, Du Q, Liu J, Ma C, et al. Direct detection of erythromycin-resistant Bordetella pertussis in clinical specimens by PCR. J Clin Microbiol. 2015;53(11):3418-22.  https://doi.org/10.1128/JCM.01499-15  PMID: 26224847 
  14. Mäkinen J, Viljanen MK, Mertsola J, Arvilommi H, He Q. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis. Emerg Infect Dis. 2001;7(6):952-8.  https://doi.org/10.3201/eid0706.010606  PMID: 11747721 
  15. Lönnqvist E, Barkoff AM, Mertsola J, He Q. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017. J Glob Antimicrob Resist. 2018;14:12-6.  https://doi.org/10.1016/j.jgar.2018.02.012  PMID: 29486357 
  16. European Centre for Disease Prevention and Control (ECDC). Increase of pertussis cases in the EU/EEA. Stockholm: ECDC; 8 May 2024. Available from: https://www.ecdc.europa.eu/en/publications-data/increase-pertussis-cases-eueea
  17. Rodrigues C, Bouchez V, Soares A, Trombert-Paolantoni S, Aït El Belghiti F, Cohen JF, et al. Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024. Euro Surveill. 2024;29(31):2400459.  https://doi.org/10.2807/1560-7917.ES.2024.29.31.2400459  PMID: 39092529 
  18. Ivaska L, Barkoff AM, Mertsola J, He Q. Macrolide resistance in Bordetella pertussis: current situation and future challenges. Antibiotics (Basel). 2022;11(11):1570.  https://doi.org/10.3390/antibiotics11111570  PMID: 36358225 
Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Milja+Miettinen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Miettinen Milja</a>, <a href="/search?value1=Alex-Mikael+Barkoff&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Barkoff Alex-Mikael</a>, <a href="/search?value1=Aino+Nyqvist&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Nyqvist Aino</a>, <a href="/search?value1=Carita+Savolainen-Kopra&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Savolainen-Kopra Carita</a>, <a href="/search?value1=Jenni+Antikainen&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Antikainen Jenni</a>, <a href="/search?value1=Jussi+Mertsola&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mertsola Jussi</a>, <a href="/search?value1=Lauri+Ivaska&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ivaska Lauri</a>, <a href="/search?value1=Qiushui+He&option1=author&noRedirect=true" class="nonDisambigAuthorLink">He Qiushui</a></span>. Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024. <a href="/content/ecdc">Euro Surveill.</a> 2024;29(49):pii=2400765. <a href="https://doi.org/10.2807/1560-7917.ES.2024.29.49.2400765" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.49.2400765</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 19 Nov 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 05 Dec 2024 </span> </p>
/content/10.2807/1560-7917.ES.2024.29.49.2400765
/content/10.2807/1560-7917.ES.2024.29.49.2400765
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error